In silico drug discovery: Unveiling potential targets in Plasmodium falciparum
Objective: Malaria, the plasmodium parasite, which causes and affects nearly half of the world's population, is the biggest human health issue. Malaria results in an annual death toll ranging from 1.2 to 2.7 million worldwide. Consequently, there is a pressing need for novel active ingredients...
Main Authors: | R. Murugesan, B. Kaleeswaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Aspects of Molecular Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949688824000054 |
Similar Items
-
In silico screening of phytochemicals from Dissotis rotundifolia against Plasmodium falciparum Dihydrofolate Reductase
by: Latif Adams, et al.
Published: (2023-05-01) -
A novel quinoline-appended chalcone derivative as potential Plasmodium falciparum gametocytocide
by: Himank Kumar, et al.
Published: (2019-01-01) -
Malária grave por Plasmodium falciparum Severe Plasmodium falciparum malaria
by: Andréia Patrícia Gomes, et al.
Published: (2011-09-01) -
Analyzing a potential drug target N-myristoyltransferase of Plasmodium falciparum through in silico approaches
by: Amit Kumar Banerjee, et al.
Published: (2012-01-01) -
Resistência do Plasmodium falciparum ao fansidar, quinina e tetraciclina Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline
by: Fernando Hélio Alencar, et al.
Published: (1982-10-01)